Related references
Note: Only part of the references are listed.Planning and core analyses for periodic aggregate safety data reviews
H. Amy Xia et al.
CLINICAL TRIALS (2011)
BAYESIAN HIERARCHICAL MODELING FOR DETECTING SAFETY SIGNALS IN CLINICAL TRIALS
H. Amy Xia et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2011)
Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team
Brenda J. Crowe et al.
CLINICAL TRIALS (2009)
Evaluating the safety of a rotavirus vaccine: the REST of the story
Joseph F. Heyse et al.
CLINICAL TRIALS (2008)
Measures for conducting comparative benefit: Risk assessment
Christy Chuang-Stein et al.
DRUG INFORMATION JOURNAL (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events
Sara Hughes et al.
PHARMACEUTICAL STATISTICS (2008)
Developing tools for the safety specification in risk management plans: lessons learned from a pilot project
Andrew J. P. Cooper et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Graphical approaches to the analysis of safety data from clinical trials
Ohad Amit et al.
PHARMACEUTICAL STATISTICS (2008)
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine
T Vesikari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Accounting for multiplicities in assessing drug safety: A three-level hierarchical mixture model
SM Berry et al.
BIOMETRICS (2004)
Forest plots: trying to see the wood and the trees
S Lewis et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Recent advancements in the analysis and presentation of safety data
C Chuang-Stein et al.
DRUG INFORMATION JOURNAL (2001)
Share Paper
